Comparison of the effectiveness of four different crosslinking agents with hyaluronic acid hydrogel films for tisslue-culture applications

被引:120
作者
Collins, M. N. [1 ]
Birkinshaw, C. [1 ]
机构
[1] Univ Limerick, Dept Mat Sci & Technol, Limerick, Ireland
关键词
hydrogel; biological applications of polymers; biomaterials; mechanical properties;
D O I
10.1002/app.25993
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
The effectiveness of four different reagents, glutaraldehyde (GTA), 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC), poly(ethyelene glycol) diglycidyl ether (EX 810), and divinyl sulfone (DVS) as crosslinkers for cast hyaluronic acid (HA) films has been evaluated. Films were prepared by casting from solution and exposed to solutions of the crosslinkers in acetone-water solution. Swelling in water and in phosphate buffered saline (PBS) was then used to assess the effectiveness of the crosslinkers. GTA-crosslinked films were found to be of low stability compared with those treated with EDC, EX 810, and DVS. Results suggest that instability in GTA-crosslinked materials arises in part from residual acid catalyst. The effects of polymer molecular weight are not uniform. With GTA-crosslinked film produced from higher molecular weight HA swells more, and this is attributed to reduced diffusion of the crosslinker, but with EDC, the opposite effect is observed, implying some additional molecular weight dependent mechanism. Differential scanning calorimetry and dynamic mechanical thermal analysis results suggest that there are no significant structural difference between the gels for each crosslinker system and only the crosslink density and moisture content alters the transitions. (c) 2007 Wiley Periodicals, Inc.
引用
收藏
页码:3183 / 3191
页数:9
相关论文
共 31 条
[1]   DSC STUDIES ON STATES OF WATER IN CROSS-LINKED POLY(METHYL METHACRYLATE-CO-N-VINYL-2-PYRROLIDONE) HYDROGELS [J].
AHMAD, MB ;
HUGLIN, MB .
POLYMER INTERNATIONAL, 1994, 33 (03) :273-277
[2]  
Balazs EA, 1987, US Patent, Patent No. [4713448A, 4713448]
[3]  
Bracke J. W., 1985, US Patent, Patent No. 4517295
[4]  
BURNS JW, 1991, Patent No. 5017229
[5]   Efficacy and safety of intraarticular hyaluronic acid in the treatment of hip osteoarthritis:: a systematic review [J].
Fernandez Lopez, J. C. ;
Ruano-Ravina, A. .
OSTEOARTHRITIS AND CARTILAGE, 2006, 14 (12) :1306-1311
[6]  
HAMILTON R, 1990, Patent No. 4937270
[7]  
HUBBELL JA, 1996, Patent No. 5567435
[8]   Thermoreversible swelling behaviour of hydrogels based on N-isopropylacrylamide with acidic comonomers [J].
Huglin, MB ;
Liu, Y ;
Velada, JL .
POLYMER, 1997, 38 (23) :5785-5791
[9]   A surface-tethered model to assess size-specific effects of hyaluronan (HA) on endothelial cells [J].
Ibrahim, Samir ;
Joddar, Binata ;
Craps, Matthew ;
Ramamurthi, Anand .
BIOMATERIALS, 2007, 28 (05) :825-835
[10]   Electrospun three-dimensional hyaluronic acid nanofibrous scaffolds [J].
Ji, Y ;
Ghosh, K ;
Shu, XZ ;
Li, BQ ;
Sokolov, JC ;
Prestwich, GD ;
Clark, RAF ;
Rafailovich, MH .
BIOMATERIALS, 2006, 27 (20) :3782-3792